Topics

IQVIA Holdings Inc. Company Profile

04:45 EST 27th January 2020 | BioPortfolio

IQVIA (NYSE:IQV) is a leading global provider of information, innovative technology solutions and contract research services focused on using data and science to help healthcare clients find better solutions for their patients. Formed through the merger of IMS Health and Quintiles, IQVIA offers a broad range of solutions that harness advances in healthcare information, technology, analytics and human ingenuity to drive healthcare forward. IQVIA enables companies to rethink approaches to clinical development and commercialization, innovate with confidence as well as accelerate meaningful healthcare outcomes. IQVIA has approximately 55,000 employees in more than 100 countries, all committed to making the potential of human data science a reality. IQVIA’s approach to human data science is powered by the IQVIA CORE™, driving unique actionable insights at the intersection of big data, transformative technology and analytics with extensive domain expertise. IQVIA’s insights and execution capabilities help biotech, medical device, and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures.


News Articles [519 Associated News Articles listed on BioPortfolio]

Iqvia Holdings (IQV) Aktie: Outsourcing von klinischen Studien und Heathcare AI?

IQVIA, ging aus IMS Health und Quintiles hervor und ermöglicht es Pharmafirmen die teuren klinischen Studien outzusourcen oder dies zu erleichtern. Studien können dadurch kostengünstiger und schnel...

IQVIA Announces Repurchase of Common Stock

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that it has agreed to purchase an aggregate of 1,000,000 shares (the “Shares”) of its common stock in a private transaction from certa...

IQVIA Holdings Inc. 2019 Q2 - Results - Earnings Call Slides

IQVIA Holdings Inc. 2019 Q3 - Results - Earnings Call Presentation

IQVIA Holdings Inc. (IQV) CEO Ari Bousbib on Q2 2019 Results - Earnings Call Transcript

IQVIA Holdings Inc. (IQV) CEO Ari Bousbib on Q3 2019 Results - Earnings Call Transcript

Iqvia leads $14m investment round in patient engagement app

Belong.Life raises $14m as part of a Series B funding round with plans to expand its patient engagement platform, using and complementing Iqviaâs solutions âto transform patient engagement,â says I...

Iqvia sees ‘a lot of runway ahead’ despite growth in Q2

Iqvia is looking to the future and opportunities in AI, after reporting $2.74bn in revenue for Q2 FY19.

PubMed Articles [12 Associated PubMed Articles listed on BioPortfolio]

Validating a popular outpatient antibiotic database to reliably identify high prescribing physicians for patients 65 years of age and older.

Many jurisdictions lack comprehensive population-based antibiotic use data and rely on third party companies, most commonly IQVIA. Our objective was to validate the accuracy of the IQVIA Xponent antib...

Ability of primary care health databases to assess medicinal products discussed by the European Union Pharmacovigilance Risk Assessment Committee.

This study measured the exposure to different categories of medicinal products discussed by the EU Pharmacovigilance Risk Assessment Committee from September to November 2018 in 4 electronic primary c...

Serological surveillance reveals patterns of exposure to H5 and H7 influenza A viruses in European poultry.

Influenza A viruses of H5 and H7 subtype in poultry can circulate subclinically, and subsequently mutate from low to high pathogenicity with potentially devastating economic and welfare consequences. ...

Antidepressant Prescriptions, Including Tricyclics, Continue to Increase in Canadian Children.

Few studies have longitudinally followed trends in antidepressant prescribing for Canadian children following the Black Box warning issued in 2004. Using a national data source, we aim to describe tre...

Current Status of Delamanid in the Management of MDR Tuberculosis.

Delamanid is a nitro-dihydro-imidazooxazole compound which was developed by a Japanese company, Otsuka Holdings inc. and has shown in-vitro and in-vivo activity against drug resistant tuberculosis. Th...

Clinical Trials [4 Associated Clinical Trials listed on BioPortfolio]

Expanded Access With Trappsol(R) Cyclo (TM) for an Individual Patient With Late Onset Alzheimer's Disease

To afford urgent access to a potential-disease modifying treatment, Dr. Diana Kerwin, in partnership with CTD Holdings, the manufacturer of Trappsol (R) Cyclo(TM), will administer the prod...

Study of Pharmacokinetics and Preliminary Efficacy in Patients With Niemann-Pick C1

This research study is being conducted to find out whether Trappsol® Cyclo™, an experimental treatment for people with Niemann-Pick disease Type C1 (NPC-1) is safe at 3 different dose l...

Study of the Pharmacokinetics of Trappsol and Effects on Potential Biomarkers of Niemann-Pick C1 (NPC1)

This research study is being conducted to find out whether Trappsol® Cyclo™, an experimental treatment for people with Niemann Pick disease Type C (NPC-1) is safe at 2 different dose le...

Frequent Fallers' Experiences of an Adapted Walking Frame, Designed to Reduce the Walking Aid's Associated Falls Risk

For some patients with mobility issues, a walking frame (commonly known as a zimmer frame - trademark of Zimmer Holdings), is provided to keep them on their feet and help them remain more ...

Companies [524 Associated Companies listed on BioPortfolio]

IQVIA Holdings Inc.

IQVIA (NYSE:IQV) is a leading global provider of information, innovative technology solutions and contract research services focused on using data and science to help healthcare c...

IQVIA Inc.

IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and contract research services to the life sciences industry. Formed through the merger ...

Integra Holdings

Founded by Yissum, Integra Holdings is a unique venture fund, focusing on an exclusive selection of biotech companies with proprietary solutions and a competitive advantage in the...

Sabre Holdings

Sabre Holdings connects people with the world's greatest travel possibilities by retailing travel products and providing distribution and technology solutions for the travel indus...

HealthTech Holdings, Inc.

HealthTech Holdings, Inc. is a health information technology holding-company, with portfolio companies including HMS, MEDHOST and Sentry Healthcare Services, Inc. HealthTec...

More Information about "IQVIA Holdings Inc." on BioPortfolio

We have published hundreds of IQVIA Holdings Inc. news stories on BioPortfolio along with dozens of IQVIA Holdings Inc. Clinical Trials and PubMed Articles about IQVIA Holdings Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of IQVIA Holdings Inc. Companies in our database. You can also find out about relevant IQVIA Holdings Inc. Drugs and Medications on this site too.

Quick Search

Relevant Topics

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...


Corporate Database Quicklinks



Searches Linking to this Company Record